	Créances Commerciales		Date
Acadia Pharmaceuticals	USD 139.44M	19.75M	2025-09
Alnylam Pharmaceuticals	USD 777.57M	187.2M	2025-12
Amgen	USD 9.57B	1.08B	2025-12
BioCryst Pharmaceuticals	USD 79.07M	6.61M	2024-12
Biogen	USD 1.85B	234M	2025-09
BioMarin Pharmaceutical	USD 790.27M	65.59M	2025-09
Cytokinetics	USD 1.81M	6.6M	2025-09
Daiichi Sankyo	JPY 695.95B	79.1B	2025-12
Enanta Pharmaceuticals	USD 40.16M	1.52M	2024-12
Esperion Therapeutics	USD 60.36M	5.75M	2024-06
Gilead Sciences	USD 4.91B	182M	2025-12
Incyte	USD 1.02B	128.52M	2025-12
Ionis Pharmaceuticals	USD 24.61M	27.97M	2025-09
Ironwood Pharmaceuticals	USD 81.89M	5.68M	2024-12
Karyopharm Therapeutics	USD 31.78M	6.82M	2024-09
Novartis	USD 8.98B	192M	2025-09
Pfizer	USD 18.12B	2.02B	2025-09
PTC Therapeutics	USD 181.62M	21.45M	2025-12
Puma Biotechnology	USD 28.1M	3.52M	2024-06
Roche Holding	CHF 11.9B	460M	2025-12
Sangamo BioSciences	USD 581K	110K	2024-06
Sarepta Therapeutics	USD 395.74M	213.86M	2025-09
TG Therapeutics	USD 265.38M	33.86M	2025-09
Ultragenyx Pharmaceutical	USD 112.54M	11.92M	2025-09
Vertex Pharmaceuticals	USD 2.05B	106.4M	2025-12
Xencor	USD 21.8M	25.75M	2025-09

PTC Therapeutics Créances Commerciales - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.